BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36139111)

  • 1. Phosphatidylethanolamine
    Zhou Q; Zhang F; Kerbl-Knapp J; Korbelius M; Kuentzel KB; Vujić N; Akhmetshina A; Hörl G; Paar M; Steyrer E; Kratky D; Madl T
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystathionine beta-synthase deficiency alters hepatic phospholipid and choline metabolism: Post-translational repression of phosphatidylethanolamine N-methyltransferase is a consequence rather than a cause of liver injury in homocystinuria.
    Jacobs RL; Jiang H; Kennelly JP; Orlicky DJ; Allen RH; Stabler SP; Maclean KN
    Mol Genet Metab; 2017 Apr; 120(4):325-336. PubMed ID: 28291718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of phosphatidylethanolamine N-methyltransferase in mice does not promote fatty acid oxidation in skeletal muscle.
    Tasseva G; van der Veen JN; Lingrell S; Jacobs RL; Vance DE; Vance JE
    Biochim Biophys Acta; 2016 Feb; 1861(2):119-129. PubMed ID: 26603903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of UCP1 by non-cell-autonomous action of PEMT.
    Johnson JM; Verkerke ARP; Maschek JA; Ferrara PJ; Lin CT; Kew KA; Neufer PD; Lodhi IJ; Cox JE; Funai K
    Mol Metab; 2020 Jan; 31():55-66. PubMed ID: 31918922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological roles of phosphatidylethanolamine N-methyltransferase.
    Vance DE
    Biochim Biophys Acta; 2013 Mar; 1831(3):626-32. PubMed ID: 22877991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice.
    Watkins SM; Zhu X; Zeisel SH
    J Nutr; 2003 Nov; 133(11):3386-91. PubMed ID: 14608048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased lipogenesis in white adipose tissue contributes to the resistance to high fat diet-induced obesity in phosphatidylethanolamine N-methyltransferase-deficient mice.
    Gao X; van der Veen JN; Hermansson M; Ordoñez M; Gomez-Muñoz A; Vance DE; Jacobs RL
    Biochim Biophys Acta; 2015 Feb; 1851(2):152-62. PubMed ID: 25463480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for hepatic scavenger receptor class B, type I in decreasing high density lipoprotein levels in mice that lack phosphatidylethanolamine N-methyltransferase.
    Robichaud JC; Francis GA; Vance DE
    J Biol Chem; 2008 Dec; 283(51):35496-506. PubMed ID: 18842588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatidylethanolamine N-methyltransferase pathway is quantitatively not essential for biliary phosphatidylcholine secretion.
    Verkade HJ; Havinga R; Shields DJ; Wolters H; Bloks VW; Kuipers F; Vance DE; Agellon LB
    J Lipid Res; 2007 Sep; 48(9):2058-64. PubMed ID: 17595447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.
    Jacobs RL; Zhao Y; Koonen DP; Sletten T; Su B; Lingrell S; Cao G; Peake DA; Kuo MS; Proctor SD; Kennedy BP; Dyck JR; Vance DE
    J Biol Chem; 2010 Jul; 285(29):22403-13. PubMed ID: 20452975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concentration of phosphatidylethanolamine in mitochondria can modulate ATP production and glucose metabolism in mice.
    van der Veen JN; Lingrell S; da Silva RP; Jacobs RL; Vance DE
    Diabetes; 2014 Aug; 63(8):2620-30. PubMed ID: 24677714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans.
    da Costa KA; Sanders LM; Fischer LM; Zeisel SH
    Am J Clin Nutr; 2011 May; 93(5):968-74. PubMed ID: 21411618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance.
    Wan S; van der Veen JN; Bakala N'Goma JC; Nelson RC; Vance DE; Jacobs RL
    FASEB J; 2019 Oct; 33(10):10986-10995. PubMed ID: 31284753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice.
    Noga AA; Vance DE
    J Biol Chem; 2003 Jun; 278(24):21851-9. PubMed ID: 12668679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling.
    van der Veen JN; Lingrell S; McCloskey N; LeBlond ND; Galleguillos D; Zhao YY; Curtis JM; Sipione S; Fullerton MD; Vance DE; Jacobs RL
    FASEB J; 2019 Apr; 33(4):5045-5057. PubMed ID: 30615497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired phosphatidylcholine biosynthesis reduces atherosclerosis and prevents lipotoxic cardiac dysfunction in ApoE-/- Mice.
    Cole LK; Dolinsky VW; Dyck JR; Vance DE
    Circ Res; 2011 Mar; 108(6):686-94. PubMed ID: 21273556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phosphatidylethanolamine N-methyltransferase on phospholipid composition, microvillus formation and bile salt resistance in LLC-PK1 cells.
    Morita SY; Ikeda N; Horikami M; Soda K; Ishihara K; Teraoka R; Terada T; Kitagawa S
    FEBS J; 2011 Dec; 278(24):4768-81. PubMed ID: 21958070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
    Li Z; Agellon LB; Allen TM; Umeda M; Jewell L; Mason A; Vance DE
    Cell Metab; 2006 May; 3(5):321-31. PubMed ID: 16679290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
    van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.